Ilkka Heiskanen

1.0k citations
31 papers · 671 indexed · h-index 14

Ilkka Heiskanen

29 papers receiving 657 citations

Peers

Ilkka Heiskanen
Comparison fields: 5 of 66
  • Nephrology 180
  • Endocrinology, Diabetes and Metabolism 172
  • Oncology 217
  • Pathology and Forensic Medicine 140
  • Cancer Research 110
Replace Akira Hirayama with:
Akira Hirayama Japan
Tohru Yashiro Japan
Francesca Torresan Italy
Catherine Cardot-Bauters France
Stanley Sidhu Australia
Angelo Giovanni Bonadio Italy
Trisha M. Shattuck United States
Jan‐Silvester Willems Sweden
Jaydira Del Rivero United States
Laure Michaud France
Ilkka Heiskanen relative to Akira Hirayama Japan Akira Hirayama's profile →
Citations per field
00.5×11.5×
Akira Hirayama · 1×
Citations per year

Countries citing papers authored by Ilkka Heiskanen

Since Specialization
Citations

This map shows the geographic impact of Ilkka Heiskanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilkka Heiskanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilkka Heiskanen more than expected).

Fields of papers citing papers by Ilkka Heiskanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilkka Heiskanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilkka Heiskanen. The network helps show where Ilkka Heiskanen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ilkka Heiskanen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ilkka Heiskanen Line = papers co-authored together Ilkka Heiskanen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202023
2 20208
3 20202
4 201932
5 201816
6 201812
7 201717
8 201710
9 20160
10 201529
11 201481
12 201343
13 20136
14 201220
15 201161
16 201013
17
Clinical Studies on Familial Adenomatous Polyposis
20001
18 199749
19 199694
20 19685

About Ilkka Heiskanen

Ilkka Heiskanen is a scholar working on Nephrology, Cancer Research and Oncology, having authored 31 papers that have together received 671 indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (8 papers), Cancer, Hypoxia, and Metabolism (6 papers), Adrenal and Paraganglionic Tumors (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers), Cardiac tumors and thrombi (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Genetic Syndromes and Imprinting (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Nephrology (180 citations), Endocrinology, Diabetes and Metabolism (172 citations) and Oncology (217 citations). Ilkka Heiskanen has collaborated with scholars based in Finland and United States. Frequent co-authors include Heikki Järvinen, Johanna Arola, Caj Haglund, Camilla Schalin‐Jäntti, Eeva Ryhänen, Timo Sane, Matti Välimäki, Harri Mustonen, Satu Maria Remes and Jaana Hagström. Their work appears in journals such as Administrative Science Quarterly, Journal of Clinical Pathology and Human Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026